<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Q2 2023 earnings on FinanClub</title>
    <link>https://finan.club/tags/q2-2023-earnings/</link>
    <description>Recent content in Q2 2023 earnings on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 12 Aug 2023 06:56:32 +0000</lastBuildDate><atom:link href="https://finan.club/tags/q2-2023-earnings/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MRK</title>
      <link>https://finan.club/us/mrk/</link>
      <pubDate>Sat, 12 Aug 2023 06:56:32 +0000</pubDate>
      
      <guid>https://finan.club/us/mrk/</guid>
      <description>score:109
Chances: Stronger-than-expected second-quarter earnings indicate the company&amp;rsquo;s financial strength. Positive results from clinical trials and collaborations in the healthcare sector. Rise in revenue and better full-year sales forecast driven by strong Keytruda cancer-drug sales. Expansion of ongoing Phase 1 dose escalation trial for breast cancer vaccine in collaboration with Cleveland Clinic.</description>
    </item>
    
    <item>
      <title>DOCS</title>
      <link>https://finan.club/us/docs/</link>
      <pubDate>Sat, 12 Aug 2023 06:55:58 +0000</pubDate>
      
      <guid>https://finan.club/us/docs/</guid>
      <description>score:39
Chances: Strong quarterly results indicate the company&amp;rsquo;s ability to perform well in the healthcare sector. Doximity&amp;rsquo;s leading digital platform for medical professionals positions it well in the telemedicine and healthcare technology industry. Earnings and revenue surprises in Q2 2023 show positive performance and potential for growth.</description>
    </item>
    
  </channel>
</rss>
